367 related articles for article (PubMed ID: 2156153)
41. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.
De Winter H; Herdewijn P
J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385
[TBL] [Abstract][Full Text] [Related]
42. Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase.
Balzarini J; Hernández AI; Roche P; Esnouf R; Karlsson A; Camarasa MJ; Pérez-Pérez MJ
Mol Pharmacol; 2003 Feb; 63(2):263-70. PubMed ID: 12527796
[TBL] [Abstract][Full Text] [Related]
43. Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8.
Tomicic MT; Friedrichs C; Christmann M; Wutzler P; Thust R; Kaina B
Mol Pharmacol; 2003 Feb; 63(2):439-49. PubMed ID: 12527816
[TBL] [Abstract][Full Text] [Related]
44. Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase.
Bennett LL; Parker WB; Allan PW; Rose LM; Shealy YF; Secrist JA; Montgomery JA; Arnett G; Kirkman RL; Shannon WM
Mol Pharmacol; 1993 Dec; 44(6):1258-66. PubMed ID: 8264563
[TBL] [Abstract][Full Text] [Related]
45. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
[TBL] [Abstract][Full Text] [Related]
46. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
Swierkosz EM; Arens MQ; Rivetna KA
J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
[TBL] [Abstract][Full Text] [Related]
47. Metabolism of the carbocyclic analogue of (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells. Incorporation of C-IVDU into DNA.
De Clercq E; Bernaerts R; Balzarini J; Herdewijn P; Verbruggen A
J Biol Chem; 1985 Sep; 260(19):10621-8. PubMed ID: 2993282
[TBL] [Abstract][Full Text] [Related]
48. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
Wildner O; Blaese RM; Candotti F
Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
[TBL] [Abstract][Full Text] [Related]
49. The bystander effect mediated by the new murine gammaherpesvirus 72--thymidine kinase/5'-fluoro-2'-deoxyuridine (MHV72-TK/5-FUdR) system in vitro.
Raslova H; Matis J; Rezuchova I; Macakova K; Berebbi M; Kudelova M
Antivir Chem Chemother; 2000 Jul; 11(4):273-82. PubMed ID: 10950389
[TBL] [Abstract][Full Text] [Related]
50. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
De Clercq E
Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
52. The cytostatic activity of 5-(1-azidovinyl)-2'-deoxyuridine (AzVDU) against herpes simplex virus thymidine kinase gene-transfected FM3A cells is due to inhibition of thymidylate synthase and enhanced by UV light (lambda = 254 nm) exposure.
Balzarini J; Andrei G; Kumar R; Knaus EE; Wiebe LI; De Clercq E
FEBS Lett; 1995 Oct; 373(1):41-4. PubMed ID: 7589430
[TBL] [Abstract][Full Text] [Related]
53. Arabinose furanosyl thymidine: uptake, phosphorylation and incorporation into DNA of mammalian cells.
Dahmen N; Kowalzick L; Spadari S; Koch G
In Vivo; 1990; 4(1):25-32. PubMed ID: 1966522
[TBL] [Abstract][Full Text] [Related]
54. Analysis of toxic and mutagenic activities of antiherpesvirus nucleosides against HeLa cells and herpes simplex virus type 1.
Suzutani T; Machida H
Mutat Res; 1992 May; 267(1):125-31. PubMed ID: 1373847
[TBL] [Abstract][Full Text] [Related]
55. (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.
Bernaerts R; Desgranges C; De Clercq E
Biochem Pharmacol; 1989 Jun; 38(12):1955-61. PubMed ID: 2545207
[TBL] [Abstract][Full Text] [Related]
56. Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus.
Bohman C; Balzarini J; Wigerinck P; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1994 Mar; 269(11):8036-43. PubMed ID: 8132526
[TBL] [Abstract][Full Text] [Related]
57. Stereoelectronic properties of five anti-HSV-1 2'-deoxynucleosides analogues with heterocyclic substituents in the 5-position: a comparison with BVDU.
Olivier A; Creuven I; Evrard C; Evrard G; Dory M; van Aerschot A; Wigerinck P; Herdewijn P; Durant F
Antiviral Res; 1994 Aug; 24(4):289-304. PubMed ID: 7993074
[TBL] [Abstract][Full Text] [Related]
58. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
Kit S; Ichimura H; De Clercq E
Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
[TBL] [Abstract][Full Text] [Related]
59. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
Honess RW; O'Hare P; Young D
J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
[TBL] [Abstract][Full Text] [Related]
60. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
